World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
72
Citations
25768
World Ranking
1716
National Ranking
736

Robert L. Murphy publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Robert L. Murphy sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 347 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Robert L. Murphy D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert L. Murphy sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 72 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Robert L. Murphy is affiliated with Northwestern University in the United States. Their research primarily focuses on the field of Medicine, with specific expertise in Infectious Diseases, Epidemiology, Molecular Biology, Oncology, and Modeling and Simulation.

Their work covers several main topics, including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Epidemiological Studies
  • Cervical Cancer and HPV Research
  • SARS-CoV-2 Detection and Testing
  • COVID-19 Pandemic Impacts
  • HIV/AIDS Research and Interventions
  • Hepatitis C Virus Research

Robert L. Murphy has coauthored publications extensively with several researchers, notably:

  • Chad J. Achenbach (59 coauthored works)
  • Lifang Hou (36 coauthored works)
  • Claudia Hawkins (31 coauthored works)
  • Mamoudou Maïga (27 coauthored works)
  • Atiene S. Sagay (25 coauthored works)

The scholar's publications appear frequently in a range of journals and platforms, including:

  • JMIR Public Health and Surveillance (14 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (8 publications)
  • Research Square (Research Square) (6 publications)
  • Journal of Medical Internet Research (5 publications)
  • Infectious Agents and Cancer (5 publications)

Recent publications authored or coauthored by Robert L. Murphy span from 2020 to 2022, covering the dynamics and implications of the COVID-19 pandemic. Notable recent papers include:

  • "Longitudinal Analysis of SARS-CoV-2 Vaccine Breakthrough Infections Reveals Limited Infectious Virus Shedding and Restricted Tissue Distribution" (2022) published in Open Forum Infectious Diseases
  • "A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy" (2020) in Journal of Medical Internet Research
  • "Has Omicron Changed the Evolution of the Pandemic?" (2022) in JMIR Public Health and Surveillance
  • "Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2" (2022) in Annals of Internal Medicine
  • "Dynamic Public Health Surveillance to Track and Mitigate the US COVID-19 Epidemic: Longitudinal Trend Analysis Study" (2020) in Journal of Medical Internet Research

The focus of these works reflects a strong involvement in epidemiological surveillance, viral detection methods, and the study of COVID-19 variant dynamics and public health responses. Their research contributes to the understanding of viral behavior, transmission patterns, and the impact of pandemic control measures.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer Than 500 CD4-Positive Cells per Cubic Millimeter

    Paul A. Volberding;Stephen W. Lagakos;Matthew A. Koch;David K. Booth

  • Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

    F van Leth;P Phanuphak;K Ruxrungtham;E Baraldi

  • Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

    Sharon A. Riddler;Richard Haubrich;A. Gregory DiRienzo;Lynne Peeples

  • Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection

    Roy M. Gulick;Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Stephanie Lustgarten

  • Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

    Gregory K. Robbins;Victor De Gruttola;Robert W. Shafer;Laura M. Smeaton

  • Endothelial Function in Human Immunodeficiency Virus-Infected Antiretroviral-Naive Subjects Before and After Starting Potent Antiretroviral Therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s

    Francesca J. Torriani;Lauren Komarow;Robert A. Parker;Bruno R. Cotter

  • High-Dose Nevirapine: Safety, Pharmacokinetics, And Antiviral Effect In Patients With Human Immunodeficiency Virus Infection

    Diane Havlir;Sarah H. Cheeseman;Margaret Mclaughlin;Robert Murphy

  • Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1.

    Frank van Leth;Prahpan Phanuphak;Erik Stroes;Brian Gazzard

  • Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile.

    Marc van der Valk;John J. P. Kastelein;Robert L. Murphy;Frank van Leth

  • Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus.

    Peter Pertel;Robert E Hirschtick;John Phillip Phair;Joan S Chmiel

  • Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.

    Claudine Duvivier;Sami Kolta;Lambert Assoumou;Lambert Assoumou;Jade Ghosn

  • ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.

    Robert L. Murphy;Scott Brun;Charles Hicks;Joseph J. Eron

  • The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.

    J. Michael Kilby;Jacob P. Lalezari;Joseph J. Eron;Margrit Carlson

  • Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

    Roy M. Gulick;Heather J. Ribaudo;Cecilia M. Shikuma;Christina Lalama

  • Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia

    Jeffrey E. Beal;Richard Olson;Lewis Lefkowitz;Linda Laubenstein

  • A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

    Remko Van Leeuwen;Christine Katlama;Robert Murphy;Kathleen Squires

  • Efficacy and Safety of Adefovir Dipivoxil With Antiretroviral Therapy: A Randomized Controlled Trial

    James Kahn;Stephen Lagakos;Michael Wulfsohn;Deborah Cherng

  • Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial.

    Richard T. Davey;Robert L. Murphy;Frank M. Graziano;Stephen L. Boswell

  • Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome

    Joseph Wheat;Richard Hafner;Michael Wulfsohn;Patricia Spencer

Frequent Co-Authors

Phyllis J. Kanki
Phyllis J. Kanki Harvard University
Christine Katlama
Christine Katlama Sorbonne University
Lifang Hou
Lifang Hou Northwestern University
Judith S. Currier
Judith S. Currier University of California, Los Angeles
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Roy M. Gulick
Roy M. Gulick Cornell University
James H. Stein
James H. Stein University of Wisconsin–Madison
Douglas A. Jabs
Douglas A. Jabs Johns Hopkins University School of Medicine
Harold A. Kessler
Harold A. Kessler Rush University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various career pathways, many of which can be supported by related online degrees. For individuals concerned about past legal issues, exploring what is the best degree for a convicted felon can help identify programs that offer second chances while building valuable skills.

Healthcare continues to expand, embracing roles like the functional medicine nurse. This career blends traditional medical knowledge with holistic approaches, often benefiting from a strong foundation in microbiological sciences.

On the administrative side, professions such as a certified professional coder play an essential role in managing healthcare data. Understanding medical terms and biological processes can improve accuracy and effectiveness in this field.

For those interested in the broader management of healthcare systems, careers in health information are promising. Checking out information about healthcare information management salary and job responsibilities can clarify how microbiology graduates fit into these vital roles.

Best Scientists Citing Robert L. Murphy

Trending Scientists

Recently Published Articles